Us Bancorp \De\ Igm Biosciences, Inc. Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 90 shares of IGMS stock, worth $1,553. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 17 429.41%

Holding current value

$1,553

Previous $0 Infinity%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$6.28 - $17.68 $458 - $1,290	73 Added 429.41%	90 $1,000
Q3 2023 Nov 03, 2023	SELL	$6.66 - $10.64 $2,537 - $4,053	-381 Reduced 95.73%	17 $0
Q2 2023 Aug 09, 2023	BUY	$8.86 - $14.0 $1,036 - $1,638	117 Added 41.64%	398 $3,000
Q1 2023 May 09, 2023	SELL	$13.74 - $25.76 $2,074 - $3,889	-151 Reduced 34.95%	281 $3,000
Q4 2022 Feb 13, 2023	SELL	$15.45 - $26.02 $15,975 - $26,904	-1,034 Reduced 70.53%	432 $7,000
Q3 2022 Oct 27, 2022	SELL	$15.42 - $27.01 $1,048 - $1,836	-68 Reduced 4.43%	1,466 $34,000
Q2 2022 Aug 01, 2022	SELL	$13.27 - $25.5 $11,982 - $23,026	-903 Reduced 37.05%	1,534 $28,000
Q1 2022 May 11, 2022	BUY	$13.42 - $29.73 $28,088 - $62,224	2,093 Added 608.43%	2,437 $65,000
Q4 2021 Feb 11, 2022	SELL	$27.59 - $66.39 $86,356 - $207,800	-3,130 Reduced 90.1%	344 $10,000
Q3 2021 Nov 10, 2021	SELL	$65.76 - $90.65 $156,180 - $215,293	-2,375 Reduced 40.61%	3,474 $229,000
Q2 2021 Aug 05, 2021	SELL	$57.98 - $96.6 $4,174 - $6,955	-72 Reduced 1.22%	5,849 $486,000
Q1 2021 Apr 28, 2021	BUY	$71.56 - $121.23 $199,723 - $338,352	2,791 Added 89.17%	5,921 $454,000
Q4 2020 Feb 04, 2021	SELL	$47.41 - $115.03 $140,428 - $340,718	-2,962 Reduced 48.62%	3,130 $276,000
Q3 2020 Nov 10, 2020	BUY	$43.0 - $84.01 $248,497 - $485,493	5,779 Added 1846.33%	6,092 $449,000
Q2 2020 Aug 07, 2020	BUY	$51.3 - $75.21 $16,056 - $23,540	313 New	313 $23,000

Others Institutions Holding IGMS

# of Institutions

Shares Held

21.4M

Call Options Held

39.5K

Put Options Held

16.5K

View Full List

About IGM Biosciences, Inc.

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $500M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

More about IGMS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account